-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JJgoH0XnhRvXr2/HwBLA2pCxmbcYq99elWIX4+KEo10TaDD7dZ9tNnrB/faeb61y yrnpK3E+7doorApRwiqFlw== 0001179110-05-016392.txt : 20050815 0001179110-05-016392.hdr.sgml : 20050815 20050815170549 ACCESSION NUMBER: 0001179110-05-016392 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050812 FILED AS OF DATE: 20050815 DATE AS OF CHANGE: 20050815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HSIA DAVID C CENTRAL INDEX KEY: 0001258176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 051027728 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS, INC. STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 4 1 edgar.xml FORM 4 - X0202 4 2005-08-12 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001258176 HSIA DAVID C C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE CORONA CA 92880 0 1 0 0 Sr. VP, Scientific Affairs Common Stock (Restricted) 2005-08-12 4 A 0 1333 0 A 61333 D Common Stock, par value $0.0033 758464 I by Family Trust Common Stock, par value $0.0033 1024218 I by Partnership Common Stock, par value $0.0033 40000 I by Trust Stock Options to Purchase Common Stock 35.11 2005-08-12 4 A 0 4000 0 A 2015-08-12 Common Stock, par value $0.0033 4000 4000 D These restricted shares of common stock, par value $0.0033, were issued pursuant to the provisions of the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. (including, but not limited to, restrictions on transferability and certain forfeiture provisions concerning unvested restricted shares). The restricted shares vest (i) fifty percent on the second anniversary of the date of grant, and (ii) fifty percent on the fourth anniversary of the date of grant. By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner. The options are to be incentive stock options to the extent permitted by law, and thereafter to be non-statutory stock options These stock options shall become exercisable in four equal annual installments commencing on August 12, 2006. /s/DAVID C. HSIA 2005-08-12 -----END PRIVACY-ENHANCED MESSAGE-----